NF-κB activation was recently shown to contribute via MLK4 to the development of intratumoral heterogeneity and enhanced radioresistance of glioblastoma by inducing a transition from a proneural to mesenchymal transcriptional GBM subtype [244,245]. The gene discussed is NFKB1; the disease is glioblastoma.